Gary Johanning is listed as an executive officer and director on 2 SEC Form D filings by 2 issuers between Sep 2011 and Jan 2023: SunnyBay BioTech, Inc. (Fremont, CA — biotechnology — 2023; $2.23M reported sold to 3 investors) and NEOTHERA BIOSCIENCES, INC. (Mountain View, CA — biotechnology — 2011; $671K reported sold to 6 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 12 years. Across those companies the filings report $2.9M sold in total.
Listed alongside Feng Wang-Johanning (2 shared filings), Bruce Keyt (1 shared filing), Dongxiao Zhang (1 shared filing), Peter Colabuono (1 shared filing), Shirley Clayton (1 shared filing) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Gary. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Gary Johanning and found 3 differences, 1 worth asking the sponsor about: Form D filed 77 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.